Cas:4055-39-4 Mitomycin A manufacturer & supplier

Chemical Name:Mitomycin A

CAS.NO:4055-39-4

Synonyms:[(1aS,8S,8aR,8bS)-6,8a-Dimethoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2,3,4]pyrrolo[1,2-a]indol-8-yl]methyl Carbamate;mitomycin-A;Mitomycin A;(1aS,8S,8aR,8bS)-8-[[(Aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-6,8a-dimethoxy-5-methylazirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione

Molecular Formula:C₁₆H₁₉N₃O₆

Molecular Weight:349.33900

HS Code:

Physical and Chemical Properties:

Melting point:159-161ºC (dec)

Boiling point:587.4ºC at 760 mmHg

Density:1.5g/cm3

Index of Refraction:1.638

PSA:130.10000

Exact Mass:349.12700

LogP:0.00350

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like [(1aS,8S,8aR,8bS)-6,8a-Dimethoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2,3,4]pyrrolo[1,2-a]indol-8-yl]methyl Carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(1aS,8S,8aR,8bS)-8-[[(Aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-6,8a-dimethoxy-5-methylazirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Mitomycin A Use and application,[(1aS,8S,8aR,8bS)-6,8a-Dimethoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazirino[2,3,4]pyrrolo[1,2-a]indol-8-yl]methyl Carbamate technical grade,usp/ep/jp grade.

Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. Mitomycin A manufacturer Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Mitomycin A supplier With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs. Mitomycin A vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. Mitomycin A factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.